Neuropeptides
Volume 46, Issue 1 , Pages 1-10 , February 2012

Vascular endothelial growth factor (VEGF) and its role in the central nervous system: A new element in the neurotrophic hypothesis of antidepressant drug action

Received 7 March 2011 ,Accepted 20 May 2011.

References 

  1. Autiero M, De Smet F, Claes F, Carmeliet P. Role of neural guidance signals in blood vessel navigation. Cardiovasc. Res. 2005;65:629–638
  2. Azam F, Mehta S, Harris AL. Mechanism of resistance to antiangiogenesis therapy. Eur. J. Cancer. 2010;46:1323–1332
  3. Bergström A, Jayatissa MN, MØrk A, Wiborg O. Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Res. 2008;1196:41–52
  4. Blumberg HP, Wang F, Chepenik LG, Kalmar JH, Edmiston E, Duman RS, et al. Influence of vascular endothelial growth factor variation on human hippocampus morphology. Biol. Psychiatry. 2008;64:901–903
  5. Brochington A, Lewist C, Wharton S, Shaw PJ. Vascular endothelial growth factor and the nervous sysyem. Neuropathol. Appl. Neurobiol. 2004;30:427–446
  6. Carmeliet P, Strokebaum E. Vascular and neuronal effect of VEGF in the nervous system: implications for neurological disorders. Cell Dev. Biol. 2002;13:39–53
  7. Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 2001;22:201–207
  8. Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem. Sci. 2003;28:488–494
  9. Cursiefen C, Chen L, Leonardo PB, Jackson D, Cao J. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 2004;7:1040–1050
  10. Eichmann A, Le Noble F, Auterio M, Carmeliet P. Guidance of vascular and neural network formation. Curr. Opin. Neurobiol. 2005;15:108–115
  11. Elfving B, Plougmann PH, Wegener G. Differential brain, but not serum VEGF levels in a genetic model of depression. Neurosci. Lett. 2010;474:13–16
  12. Fabel K, Fabel K, Tam B, Kaufer D, Baiker A, Simmons N, et al. VEGF is necessary for exercise-induced adult hippocampal neurogenesis. Eur. J. Neurosci. 2003;18:2803–2812
  13. Ferrara N. Vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 2009;29:789–791
  14. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997;1:4–25
  15. Folkman J, D’Amore PA. Blood vessel formation: what is its molecular basis?. Cell. 1996;87:1153–1155
  16. Greene J, Banasr M, Lee B, Warner-Schmidt J, Duman RS. Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology. 2009;1–10
  17. Harms KM, Li L, Cunningham LA. Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1-regulated VEGF signaling. PloS ONE. 2010;5(3):e9767
  18. Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signaling and therapeutic inhibition. Cell. Signal. 2007;19:2003–2012
  19. Iga J-ichi, Ueno S-ichi, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S, et al. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2007;31:658–663
  20. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. PNAS. 2002;18:11946–11950
  21. Joo J-Y, Kim B-W, Lee J-S, Park J-Y, Kim S, Yun Y-J, et al. Activation of NMDA receptors increases proliferation and differentiation of hippocampal neural progenitor cells. J. Cell Sci. 2007;120:1358–1370
  22. Kahl KG, Bens S, Ziegler K, Rudolf S, Kordon A, Dibbelt L, et al. Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. Psychneuroendocrinology. 2009;34:353–357
  23. Khaibullina AA, Rosenstein JM, Krum JM. Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures. Brain Res. Dev. Brain Res. 2004;148:59–68
  24. Kim WB, Choi M, Kim Y-S, Park H, Lee H-R, Yun C-O, et al. Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin. Cell. Signal. 2008;20:714–725
  25. Kułak W, Sobaniec W. Mechanisms of damage and plasticity of brain. Terapia. 2006;10:56–59
  26. Lee H-T, Chang Y-C, Tu Y-F, Huang C-C. VEGF-A/VEGFR2 signaling leading to cAMP response element-binding protein phosphorylation is a shared pathway underlying the protective effect of preconditioning on neurons and endothelial cells. J. Neurosci. 2009;29:4356–4368
  27. Lee E, Son H. Adult hippocampal neurogenesis and related neurotrophic factors. BMB reports. 2009;239–244
  28. Li B, Xu W, Luo C, Gozal D, Liu R. VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Mol. Brain Res. 2003;111:155–164
  29. Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S. Serotonin (4) (5-HT(4)) receptor agonists are putative antidepressants with rapid onset of action. Neuron. 2007;55:712–725
  30. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingström A. Increased neurogenesis in a model of electroconvulsive therapy. Biol. Psychiatry. 2000;47:1043–1049
  31. Mani N, Khaibullina A, Krum JM, Rosenstein JM. Astrocyte growth effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical explants: receptor mediation and signal transduction pathways. Exp. Neurol. 2005;192:394–406
  32. Mani N, Khaibullina A, Krum JM, Rosenstein JM. Vascular endothelial growth factor enhances migration of astroglial cells in subventricular zone neurosphere cultures. J. Neurosci. Res. 2010;88:248–257
  33. Manoonkitiwongsa PS, Schultz RL, McCreery DB, Whitter EF. Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J. Cerebr. Blood Flow Metab. 2004;24:693–702
  34. Maurer MH, Tripps WKC, Feldman RE, Kuschinsky W. Expression of vascular endothelial growth factor and its receptors in rat neural stem cells. Neurosci. Lett. 2003;344:165–168
  35. McCloskey DP, Croll SD, Scharfman HE. Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures. J. Neurosci. 2005;25:8889–8897
  36. McCloskey DP, Hintz TM, Scharfman HE. Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effects. Brain Res. Bull. 2008;76:36–44
  37. Mukouyama YS, Shin D, Britsch S, Taniguchi M, Anderson DJ. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell. 2002;109:693–705
  38. Nakamura, K., Tan, F., Li, Z., Thiele, C.J., 2010. NGF activation of TrkA inducesvascular endothelial growth factor expression via induction of hypoxia inducible-factor 1-. Mol. Cell. Neurosci. doi:10.1016/j.mcn.2010.12.002.
  39. Namiecińska M, Marciniak K, Nowak JZ. VEGF as an angiogenic, neurotrophic, and neuroprotective factor. Postępy Hig. Med. Dosw. 2005;59:573–583
  40. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB. 1999;13:9–22
  41. Ogunshola OO, Antic A, Donoghue MJ, Fan S-Y, Kim H, Stewart WB, et al. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem. 2002;277:11410–11415
  42. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signaling-in control of vascular function. Nat. Rev. Mol. Cell Biol. 2006;7:359–371
  43. Proia P, Schiera G, Mineo M, Ingrassia AMR, Santoro G, Savettieri G, et al. Astrocytes shed extracellular vesicles that contain fibroblast growth factor-2 and vascular endothelial growth factor. Int. J. Mol. Med. 2008;21:63–67
  44. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Cell Biol. 1993;90:7533–7537
  45. Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 2001;114:853–865
  46. Rosenstein JM, Krum JM. New roles for VEGF in nervous tissue–beyond blood vessels. Exp. Neurol. 2004;187:246–253
  47. Rosenstein JM, Mani N, Khaibullina A, Krum JM. Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons. J. Neurosci. 2003;23:11036–11044
  48. Ruiz De Almodovar C, Lambrechts D, Mazzone M, Carmeliet P. Role and therapeutic potential of VEGF in the nervous system. Physiol. Rev. 2009;89:607–648
  49. Schratzberger P, Schratzberger G, Silver M, Curry C, Kearney M, Magner M, et al. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nature. 2000;6:405–413
  50. Segi-Nishida E, Warner-Schmidt JL, Duman RS. Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. PNAS. 2008;32:11352–11357
  51. Senger DR, Galli SJ, Dvorak AM, Peruzzi CA, Havrey VS, Dvorak MF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983–985
  52. Strokebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. BioEssays. 2004;26:943–954
  53. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, et al. VEGF-induced neuroprotection, neurogenesis and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 2003;111:1843–1851
  54. Sun F-Y, Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci. Res. 1999;79:180–184
  55. Tamburella A, Micale V, Navarria A, Drago F. Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats. Prog. Neuropsychopharmacol Biol Psychiatry. 2009;33:1205–1210
  56. Tassona, E., Maran, C., Masola, V., Bradaschia, A., Garbisa, S., Onisto, M., 2010. Antidepressant hyperforin up-regulates VEGF in CNS tumor cells. Pharmacol. Res. doi:10.1016/j.phrs.2010.09.005.
  57. Terman BI, Stoletov KV. VEGF and tumor angiogenesis. Einstein Q. J. Biol. Med. 2001;18:59–66
  58. Tsai S-J, Hong C-J, Liou Y-J, Chen T-J, Chen M-L, Hou S-J, et al. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder. Psychiatry Res. 2009;169:113–117
  59. Ventriglia M, Zanardini R, Pedrini L, Placentino A, Nielsen MG, Gennarelli M, et al. VEGF serum levels in depressed patients during SSRI antidepressant treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2009;33:146–149
  60. Vicale M, Leggio GM, Mazzola C, Drago F. Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal model of amnesia. Brain Res. 2006;1121:207–215
  61. Viikki M, Anttila S, Kampman O, Illi A, Huuhka M, Setälä-Soikkeli E, et al. Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression. Neurosci. Lett. 2010;477:105–108
  62. Wada T, Haigh JJ, Ema M, Hitoshi S, Chaddah R, Rossant J, et al. Vascular endothelial growth factor directly inhibits primitive neural stem cell survival but promotes definitive neural stem cell survival. J. Neurosci. 2006;26:6803–6812
  63. Warner-Schmidt JL, Duman RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. PNAS. 2007;11:4647–4652
  64. Warner-Schmidt JL, Duman RS. VEGF as a potential target for therapeutic intervention in depression. Curr. Opin. Pharmacol. 2008;8:14–19
  65. Wick A, Wick W, Weltenberger J, Weller M, Dichgans J, Schulz JB. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J. Neurosci. 2002;22:6401–6407
  66. Yang S-Z, Zhang L-M, Huang Y-L, Sun F-Y. Distribution of Flk-1 and Flt-1 receptors in neonatal and adult rat brains. Anat. Rec. 2003;274A:851–856
  67. Zachary I. Integration of mitogenic and migratory signals from G-Protein-coupled receptor and tyrosine kinases. Biochem. Soc. Trans. 2003;31:1171–1177
  68. Zhang ZG, Zhang L, Jiang Q, Zhang R. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 2000;106:829–838
  69. Zhu Y, Jin K, Mao XO, Greenberg DA. Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression. FASEB. 2003;17:186–193

PII: S0143-4179(11)00044-8

doi: 10.1016/j.npep.2011.05.005

Neuropeptides
Volume 46, Issue 1 , Pages 1-10 , February 2012

Article Tools

* Image Usage & Resolution